Pharmaceuticals

Did You Receive an Email Requiring Registration to the State’s PMP? - 02/28/2024

TMA can confirm that an email sent Friday afternoon asking physicians to register for a PMP Aware account are indeed legitimate; however, there is no deadline to register.


Cannabidiol Takes a Big Step Toward Respectability - 01/25/2024

In September, the DEA issued an order listing all drugs approved by the U.S. Food and Drug Administration that contain cannabidiol but no more than 0.1 percent of the chief psychoactive agent in cannabis as Schedule V drugs — those with the least potential for abuse. So far, Epidiolex is the only medication that fits that description.


Medicare Part B Inflation Rebate Takes Effect, Lowering Copays - 06/27/2023

A new federal law requires drug companies to rebate Medicare if they raise certain drug prices higher than the rate of inflation, which has translated into lower copays for some Medicare patients.


Pharmacy Rule Opens Door to Improve Access to Low-Cost Medications - 02/06/2023

Given the high cost of medications, pharmacies should be sharing low-cost options with patients and allowing them to transfer their prescriptions as needed – without imposing additional administrative hassles on physician practices.


Counterfeit Medications Proliferate in Patient Care – and They’re Not Just Illicit Opioids - 01/31/2023

Counterfeit medications are a growing problem that can undermine medical treatment, and all physicians can help prevent their spread by asking patients simple questions.


Nationwide Adderall Shortage Expected to Last Through 2022 - 10/31/2022

The U.S. Food and Drug Administration (FDA) expects a nationwide shortage of Adderall and Adderall IR to extend through the end of the year, following manufacturing delays by the largest producer of Adderall in the country, Teva Pharmaceuticals LLC.


Are You Ready for Changes to Opioid Prescribing in Texas? - 10/14/2022

Beginning Sept. 1, all prescribers will be required to set up an account with the state’s prescription monitoring program, known as PMP Aware. The Texas State Board of Pharmacy will also begin issuing new official prescription forms that include advanced security features designed to help deter fraud.


Biden Executive Order Likely to Prompt Rulemaking on Noncompetes - 07/19/2021

Directly and indirectly, the Biden administration’s wide-ranging Executive Order on Promoting Competition in the American Economy features myriad implications for health care and physician practices. The executive order, issued earlier this month, takes aim at hospital and insurance market consolidation, noncompete agreements, lack of competition among drug manufacturers, and exorbitant costs of prescription drugs and hearing aids.


Pharmacy Board Limits Chloroquine Prescriptions - 08/05/2020

Per the National Institutes of Health (NIH) COVID-19 Treatment Guidelines, which cites insufficient clinical data, the Texas Medical Association COVID-19 Task Force recommends against using chloroquine or hydroxychloroquine to treat COVID-19, “except in a clinical trial.”


PMP Checks Won’t Be Necessary for In-Facility Medications, TMB Says - 02/21/2020

Thanks to Texas Medical Association advocacy, the Texas Medical Boardhas refocused its guidance on when physicians will be required to check the Texas Prescription Monitoring Program (PMP) before prescribing certain medications starting March 1.


Making Prescribing Less Painful for Physicians - 02/15/2020

I won’t be surprised if physicians around the state are feeling a little angst and anger over the coming March 1 requirement for physicians to check the Texas prescription monitoring program (PMP) before writing prescriptions for opioids, benzodiazepines, barbiturates, and carisoprodol. I don’t fault them one bit. This is just one more administrative burden placed on physicians. But I want all of you to understand just how much worse it would have been without the intervention of the Texas Medical Association.


TMA Urges Public Education As Hemp-Based Products Become Legal - 10/16/2019

State health officials should take steps to ensure that a new law that legalizes the production and sale of hemp and some hemp products helps Texas physicians protect the health of patients who use those products. The Texas Medical Association sent that message in a letter last week to the Department of State Health Services, which was taking comments related to implementation of House Bill 1325.


$18 Million Grants to Help Texas Fight Opioid Abuse - 08/12/2019

More than 70 Texas health institutions have received almost $18 million in federal funds to combat the ongoing nationwide opioid epidemic.


TMA Pushing To Delay PMP Mandate, Buy Time for Integration With EHRs - 06/19/2019

Starting Sept. 1, physicians will be required to check the PMP before issuing any prescription for opioids, barbiturates, benzodiazepines, or carisoprodol, a mandate the Texas Legislature passed during the 2017 session. As this year’s session of the legislature enters its back stretch, TMA is hoping to persuade lawmakers to delay that mandate until March 2020 to allow for a widespread rollout of PMP-EHR integration.


Keep Your Patients and Practice Safe from Opioid Prescription Fraud - 06/19/2019

If you prescribe opioids, it’s important to protect your practice and your patients from fraud and substance-use disorder. One way to ensure that patients accurately follow your prescription is to have them sign an informed consent and opioid treatment agreement.


Google Your Way To Disposing Of Unused Drugs? - 03/21/2019

If you’re looking for a way to help your patients put a dent in the nation’s opioid epidemic, look no further than Google Maps.  Google Maps recently added a search feature that will make it easier for your patients to dispose of unwanted and unused medications.  


Pharmacy Board Nixes Proposal That Could’ve Broadened Pharmacists’ Scope - 03/14/2019

Medicine’s objections were strong, and the state’s draft rules allowing pharmacists to perform medication therapy management services aren’t going to make it after all.


New Prescription Forms Taking More Than Eight Weeks To Deliver, State Says - 03/11/2019

Update March 11: New official prescription forms for certain controlled substances could take longer than two months to receive, state health officials say.  


Bypassing the Middle Man: Should Texas Allow Physician Dispensing? - 02/11/2019

The Texas Medical Association supports allowing physicians to dispense out of their offices, and TMA and the Texas Academy of Family Physicians (TAFP) are supporting business groups and other leaders as they mount a legislative effort to bring the practice to Texas. Proponents are wielding data that illustrates potential benefits like reduced medication costs and increased patient adherence to their drug regimens.


Is the PMP Working for You? - 01/16/2019

The Texas Medical Association, in collaboration with the Center for Health Communication at The University of Texas at Austin, invites you to share your expertise on using the Prescription Monitoring Program to help care for your patients.


Update: Glitches With State's Schedule II Prescription Forms Fixed - 09/21/2018

Some physicians have not been able to order new prescription forms for certain controlled substances because of problems with the state’s IT system, and the texas.gov website.


Following National Trend, Texas’ Opioid Prescriptions Drop - 05/04/2018

In a sign that efforts to curb prescription-drug abuse are taking hold, the number of opioid prescriptions written in Texas and nationwide has fallen significantly since 2013, a study released last month shows.


Getting Patients to Take Their Meds - 04/19/2018

Patients need to take the medicines you prescribe so they can get well or feel better. New payment models reward you when they do. Here are some tips for helping patients stay with their medication regimen.


Houston Man Convicted in $50 Million Drug Scheme - 03/07/2018

A former president of a Houston-based pharmaceutical company has been convicted on charges stemming from a drug diversion scheme.


FDA Says No to Prescription Opioid Cough Meds for Children - 01/17/2018

FDA officials announced recently that prescription cough and cold medications that contain codeine or hydrocodone should not be given to patients younger than 18 years because the medicines’ risks outweigh their benefits in children.